Last reviewed · How we verify

NCT05827445

Cutaneous Sensory Block Area of the Laparoscopic Assisted Transversus Abdominis Plane Block

Completed Last updated 22 August 2025
What this trial tests

trial in Cholecystolithiasis in 30 participants. Completed in 31 December 2022.

Timeline
15 February 2022
Primary endpoint
10 October 2022
31 December 2022

Quick facts

Lead sponsorNordsjaellands Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date15 February 2022
Primary completion10 October 2022
Estimated completion31 December 2022
Sites1 location across Denmark

Conditions studied

Sponsor

Nordsjaellands Hospital

Who can join

18 and older, any sex, with Cholecystolithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to assess the size and location of cutaneous sensory block area after dual laparoscopic assisted transverse abdominis plane block (L-TAP) with ropivacaine in patients undergoing laparoscopic cholecystectomy. L-TAP is applied as a medial subcostal infiltration between midclavicular and central sternal lines and a lateral subcostal infiltration between midclavicular and anterior axillary line bilaterally.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cholecystolithiasis

Currently open trials in the same condition.

Other Nordsjaellands Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05827445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing